Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.

Por Johnston, Rhona, Uthman, Olalekan, Cummins, Ewen, Clar, Christine, Royle, Pamela, Colquitt, Jill, Tan, Bee Kang, Clegg, Andrew, Shantikumar, Saran, Court, Rachel, O'Hare, J Paul, McGrane, David, Holt, Tim, Waugh, Norman
Publicado no Health Technol Assess (2017)